European Society of Cardiology Profile Banner
European Society of Cardiology Profile
European Society of Cardiology

@escardio

Followers
146,374
Following
1,962
Media
4,287
Statuses
29,771
Explore trending content on Musk Viewer
Pinned Tweet
@escardio
European Society of Cardiology
4 days
In just over a week, the global #cardiology community will unite at #ESCCongress 2024. Are you ready to be part of it? Unable to join us in London? ESC Congress Online brings all the action to you!
Tweet media one
2
26
72
@escardio
European Society of Cardiology
4 years
. @escardio does not endorse the unfortunate personal post by one of its social media ambassadors. Diego Araiza has publicly apologised and will no longer be an ambassador for the society, as his message infringed ESC social media guidelines.
418
2K
3K
@escardio
European Society of Cardiology
2 years
#ADVOR trial: acetazolamide added to intravenous loop diuretics decreases congestion within 3 days in patients with acute decompensated #heartfailure . #ESCCongress
Tweet media one
9
567
1K
@escardio
European Society of Cardiology
2 years
#DELIVER trial: dapagliflozin reduces the risk of #cardiovascular death or worsening #heartfailure in HF patients with mildly reduced and preserved ejection fraction. #ESCCongress
Tweet media one
6
505
1K
@escardio
European Society of Cardiology
4 years
ESC 2020 Guidelines for non-ST elevation acute coronary syndrome just released #ESCCongress #ESCGuidelines #cardiotwitter #MedTwitter
Tweet media one
Tweet media two
Tweet media three
Tweet media four
8
679
1K
@escardio
European Society of Cardiology
2 years
#SECURE trial: polypill containing aspirin, atorvastatin and ramipril leads to clinically relevant reductions in recurrent #cardiovascular events in post-myocardial infarction patients. #ESCCongress
Tweet media one
19
485
1K
@escardio
European Society of Cardiology
1 year
#Semaglutide improves heart failure-related symptoms and physical function and results in greater weight loss compared with placebo in patients with #HFpEF and #obesity ⬇️ #ESCCongress STEP-HFpEF trial
Tweet media one
9
490
1K
@escardio
European Society of Cardiology
5 years
Share your technology or innovation with the cardiac community. Two great opportunities to present your digital health solutions during ESC Congress / ESC Digital Summit 2019. Submit by 28 June
19
199
931
@escardio
European Society of Cardiology
2 years
#TIME trial: randomised trial in more than 21,000 patients with high blood pressure has concluded that protection against heart attack, stroke and vascular death is not affected by whether antihypertensive medications are taken in the morning or evening. #ESCCongress
Tweet media one
12
471
990
@escardio
European Society of Cardiology
1 year
Tweet media one
4
406
954
@escardio
European Society of Cardiology
1 year
Statin use is associated with lower risk of stroke in patients with #AtrialFibrillation ⬇️ #EHRA2023 #afib #EPeeps #EHRA_ESC
Tweet media one
8
335
936
@escardio
European Society of Cardiology
5 years
JUST RELEASED: 2019 #ESGuidelines on Diabetes, Pre-Diabetes and Cardiovascular Diseases - what's new? what has changed? what are the main 2019 recommendations? #ESCCongress #cardiotwitter
Tweet media one
Tweet media two
Tweet media three
5
585
918
@escardio
European Society of Cardiology
2 years
#REVIVED trial: Percutaneous coronary intervention does not reduce all-cause mortality or #heartfailure hospitalisation in patients with severe left ventricular dysfunction and extensive #coronary artery disease. #ESCCongress
Tweet media one
9
408
866
@escardio
European Society of Cardiology
2 years
#INVICTUS trial: VKA reduce #cardiovascular events and mortality, without increasing major bleeding, compared to rivaroxaban in patients with rheumatic heart disease and #atrialfibrillation . #ESCCongress
Tweet media one
8
371
877
@escardio
European Society of Cardiology
1 year
Sacubitril/valsartan shows benefit in heart failure with ejection fraction above 40% 👇 #HeartFailure2023 #HF #HFA_ESC #PARAGLIDE_HF #HFpEF
Tweet media one
13
319
862
@escardio
European Society of Cardiology
4 years
NEW @escardio Guidance for the Diagnosis and Management of CV Disease during the COVID-19 Pandemic #cardiotwitter #medtwitter #COVID ー19 #COVID19
Tweet media one
Tweet media two
Tweet media three
14
558
754
@escardio
European Society of Cardiology
3 years
#EMPEROR -Preserved trial: empagliflozin reduces the risk of a composite of #cardiovascular death or hospitalisation for #heartfailure in patients with #HFpEF with or without #diabetes #ESCCongress
Tweet media one
7
347
692
@escardio
European Society of Cardiology
1 year
In iron-deficient patients with #HeartFailure and reduced or mildly reduced left ventricular ejection fraction ( #LVEF ), intravenous ferric carboxymaltose (FCM) is associated with a reduced risk of the composite outcome of total CV hospitalisation and CV death through 52 weeks
Tweet media one
5
224
603
@escardio
European Society of Cardiology
1 year
#Anticoagulants cause bleeding without preventing #stroke in patients with atrial high rate episodes (AHRE), but without ECG-diagnosed #Afib ⬇️ #ESCCongress NOAH-AFNET 6 trial #AHRE
Tweet media one
5
240
610
@escardio
European Society of Cardiology
5 years
Man vs machine: will AI replace human intelligence? Have your say & play an active role during #ESCDigital Summit 2019 - the only digital health event dedicated to cardiology. Register by 5 August for the greatest savings
21
147
526
@escardio
European Society of Cardiology
6 years
We hope you are all enjoying your weekend! Happy Sunday with an apical HOCM parasternal short axis 😀 #cardiotwitter #cardiology
21
221
554
@escardio
European Society of Cardiology
2 years
#FRAME_AMI trial: Selection of non-infarct related artery lesions for intervention using fractional flow reserve is superior to routine angiography-based selection in patients with acute #myocardialinfarction and multivessel disease. #ESCCongress
Tweet media one
6
234
560
@escardio
European Society of Cardiology
1 year
#Afib ablation is associated with lower rates of death, urgent heart transplantation or left ventricular assist device (LVAD) implantation compared with medical therapy in patients with end-stage #HeartFailure #ESCCongress CASTLE-HTx trial - Catheter ablation versus medical
Tweet media one
1
250
549
@escardio
European Society of Cardiology
2 years
#eBRAVE_AF trial: #AFib screening using conventional smartphones more than doubles the detection and treatment rate in older people compared to routine screening. #ESCCongress
Tweet media one
5
250
556
@escardio
European Society of Cardiology
4 years
2020 ESC Guidelines for the diagnosis and management of #atrialfibrillation just released #ESCCongress #afib #cardiotwitter #ESCGuidelines
Tweet media one
3
322
533
@escardio
European Society of Cardiology
3 years
#MASTERDAPT trial: 1 month of #DAPT following #stent implantation in high bleeding risk patients preserves ischaemic benefits and reduces bleeding risk #ESCCongress
Tweet media one
5
255
535
@escardio
European Society of Cardiology
3 years
What's new in the #ESCGuidelines for Diagnosis and Treatment for Acute and Chronic #HeartFailure ? 👇 #ESCCongress #cardiotwitter #medtwitter #HF #cardiology
Tweet media one
5
246
518
@escardio
European Society of Cardiology
4 years
#EMPEROR -Reduced trial: empagliflozin prevents both serious #heartfailure events and serious #kidneyfailure events in patients with #HFrEF #ESCCongress
Tweet media one
Tweet media two
Tweet media three
2
268
502
@escardio
European Society of Cardiology
1 year
A randomised trial involving all hospitals in London, UK, has found no difference in survival at 30 days in patients with resuscitated cardiac arrest in the community who were taken by ambulance to a #cardiacarrest centre compared with those delivered to the geographically
Tweet media one
5
204
487
@escardio
European Society of Cardiology
1 year
NEW: 2023 #ESCGuidelines for the management of #cardiomyopathies 👉 #ESCCongress
Tweet media one
0
228
484
@escardio
European Society of Cardiology
1 year
Early initiation of the sodium glucose co-transporter 2 ( #SGLT2 ) inhibitor dapagliflozin did not result in a statistically significant improvement in diuretic efficiency relative to structured usual care in hospitalised patients with acute decompensated heart failure (ADHF).
Tweet media one
3
188
478
@escardio
European Society of Cardiology
6 years
How to select the best myocardial #revascularization strategy for a challenging patient? 2018 ESC/EACS Guidelines on Myocardial Revascularization have been released @escardio @EACTS @ESC_journals #ESCcongress #ESCGuidelines
Tweet media one
Tweet media two
Tweet media three
1
365
462
@escardio
European Society of Cardiology
1 year
Remote monitoring reduces #HeartFailure hospitalisations and improves quality of life 👇 #HeartFailure2023 #HF #HFA_ESC #MONIT0R_HF
Tweet media one
1
196
460
@escardio
European Society of Cardiology
4 years
We are deeply saddened by the passing of our dear friend and colleague Prof Maurizio Galderisi who succumbed to COVID-19 this morning. Our thoughts go out to his family. The cardiovascular community has lost an inspiring leader. We will miss him dearly. #EACVI #COVID19
Tweet media one
33
169
448
@escardio
European Society of Cardiology
2 years
'To me, it's the greatest event on the planet' 😊 👇 Be part of the onsite magic at #ESCCongress 2022. Catch up with old friends and meet new colleagues in person. Find out more & register 😊 #cardiotwitter #medtwitter
26
92
425
@escardio
European Society of Cardiology
5 years
'Bible of CV Medicine'😊as one of our fans refers to the ESC Textbook of Cardiovascular Medicine, 2019 BMA Book Award 1st Prize winner in #cardiology ESC Professional Member? You have full access to its online version #ESCCardioMed Make the most of it
Tweet media one
7
90
389
@escardio
European Society of Cardiology
2 years
From tapas to tulips 🌷 C U in #Amsterdam for #ESCCongress where the magic continues ‼️ Thank you all. 🥰
Tweet media one
3
88
431
@escardio
European Society of Cardiology
3 years
#TOMAHAWK trial: early coronary #angiography in out-of-hospital #CardiacArrest patients without ST-segment elevation is not superior to a delayed/selective approach #ESCCongress
Tweet media one
4
174
420
@escardio
European Society of Cardiology
6 years
Austin Flint murmur is assoc w/ severe aortic regurgitation. The result of mitral valve leaflet displacement & turbulent mixing of anterograde mitral & retrograde aortic flow. Thank you @Doc_Tiger for this video. #CVimaging #cardiotwitter #cardiacimaging #EACVI
5
216
416
@escardio
European Society of Cardiology
3 years
#APAF -CRT trial: ablation plus #CRT is superior to pharmacological rate control in reducing mortality in severely symptomatic permanent #AFib patients with a narrow QRS #ESCCongress
Tweet media one
10
205
410
@escardio
European Society of Cardiology
3 years
NEW: #ESCGuidelines for Diagnosis and Treatment for Acute and Chronic #HeartFailure Algorithm for the treatment of patients with advanced #HF 👇 Do you know how to select patients with advanced heart failure for mechanical support? 👇 #ESCCongress
Tweet media one
Tweet media two
6
221
391
@escardio
European Society of Cardiology
2 years
#ESCardioEd challenge ❤️‍🩹 52 yo 🧑‍🦳G2P2, pw/ chest pain ❤️‍🩹 Her mother passed away 3d ago ❤️‍🩹 Trop. T = 3.90 ng/dl ⬆️ ❤️‍🩹 ECG: Inf. ST elev. ❤️‍🩹 CAG & LVgram ⬇️ What's your dx? A. #takotsubo B. #SCAD C. #NSTEMI D. #takotsubo (+) #SCAD E. #ARVD #cardiotwitter #ESCYoung
126
85
385
@escardio
European Society of Cardiology
2 years
You cannot miss this one: check out the new 2022 #PulmonaryHypertension guidelines! #ESCCongress #ESCGuidelines #cardiotwitter #medtwitter
Tweet media one
6
162
376
@escardio
European Society of Cardiology
4 years
The CV scientific meeting of the year is moving online, full speed ahead: #ESCCongress 2020-Challenging Times, Infinite Possibilities Sat 29 August-Tue 1 September Details on free registration will be shared soon. #cardiotwitter #Cardiology #MedTwitter
Tweet media one
5
185
368
@escardio
European Society of Cardiology
1 year
NEW: 2023 #ESCGuidelines for the management of #CardiovascularDisease in patients with #diabetes 👉 #ESCCongress #CVD
Tweet media one
0
171
365
@escardio
European Society of Cardiology
1 year
The traditional Chinese medicine qiliqiangxin reduces hospitalisation for #HeartFailure and CV death in patients with #HF and a reduced ejection fraction ( #HFrEF ) ⬇️ #ESCCongress QUEST trial
Tweet media one
5
124
364
@escardio
European Society of Cardiology
1 year
Upgrade to cardiac resynchronisation therapy with a defibrillator (CRT-D) reduces morbidity & mortality and improves left ventricular reverse remodelling compared to an ICD in select patients with #HeartFailure and #HFrEF and intermittent or permanent RV pacing ⬇️ #ESCCongress
Tweet media one
2
150
363
@escardio
European Society of Cardiology
6 years
Just released: 2018 European Society of Cardiology/European Society of Hypertension #Guidelines on Arterial #Hypertension @escardio @ESH_Annual @ESC_journals #ESCcongress #ESCGuidelines
Tweet media one
Tweet media two
Tweet media three
4
308
350
@escardio
European Society of Cardiology
4 years
From today until 31 July, enjoy free access to all ESC 365 content. Explore more than 120,000 presentations, slides, videos, abstracts from past ESC Congresses and across all ESC subspecialty congresses #cardiotwitter #medtwitter #ESCYoung #cardiology
Tweet media one
4
198
340
@escardio
European Society of Cardiology
3 years
Start planning! #ESCCongress will be back on the road beginning next year. We can’t wait to see you again 🤗 #cardiotwitter #medtwitter #cardiology #ESCYoung #ESCSoT #heartteam
Tweet media one
13
82
317
@escardio
European Society of Cardiology
1 year
A pragmatic natriuresis guided diuretic approach in patients with acute #heartfailure significantly increases 24-hour natriuresis without impacting all-cause mortality or heart failure rehospitalisation. #ESCCongress PUSH-AHF trial - Natriuresis guided therapy in acute heart
Tweet media one
0
128
309
@escardio
European Society of Cardiology
6 years
According to the 2018 #ESCGuidelines for a Fabulous #Xmas Holiday, as long as you spend your winter celebrations w/ good humor, hope & positivity for you, your loved ones & your patients… any dessert is recommended 😃 Our best wishes to you all & Happy New Year!
Tweet media one
7
203
298
@escardio
European Society of Cardiology
2 years
#PERSPECTIVE trial: sacubitril/valsartan does not change cognitive function, compared with valsartan, in patients with #heartfailure and mildly reduced or preserved ejection fraction. #ESCCongress
Tweet media one
0
140
295
@escardio
European Society of Cardiology
5 years
JUST RELEASED: 2019 #ESCGuidelines for Acute Pulmonary Embolism - what's new? what has changed? what are the main 2019 recommendations? @escardio #ESCcongress #ESCCoT #cardiotwitter
Tweet media one
Tweet media two
Tweet media three
2
220
294
@escardio
European Society of Cardiology
6 months
We have all lost a great man. Alain Cribier was a revolutionary, devoting his life to innovation, enabling millions of patients to live longer lives. « This passing of Alain Cribier is very sad news. He was a giant in his field and combined his great expertise with a touching
Tweet media one
7
81
294
@escardio
European Society of Cardiology
3 years
#GUIDE -HF trial: haemodynamic guided management may reduce #heartfailure hospitalisations in patients with earlier stage #HF #ESCCongress
Tweet media one
0
148
291
@escardio
European Society of Cardiology
6 years
Santa Claus who is now 75-years-old, has been describing shortness of breath on minimal exertion for the last 6 months. Due to obesity, he is hypercholesterolemic and diabetic on insulin. #EACVI #cardiotwitter #CVimaging #ESCardioEd #medtwitter
30
131
284
@escardio
European Society of Cardiology
1 year
Friends, If you liked our visual summaries for the #ESCCongress hot lines, you can find them here 🤗
Tweet media one
4
112
285
@escardio
European Society of Cardiology
2 years
#ALL_HEART trial: allopurinol has failed to reduce the primary endpoint of nonfatal myocardial infarction, nonfatal stroke or #cardiovascular death in patients with ischaemic heart disease. #ESCCongress
Tweet media one
1
121
288
@escardio
European Society of Cardiology
1 year
Immediate multivessel #PCI is non-inferior to staged multivessel PCI for reducing death and ischaemic events in patients with #STEMI and multivessel coronary artery disease ⬇️ #ESCCongress MULTISTARS AMI trial - Multivessel immediate versus staged revascularisation in STEMI
Tweet media one
3
132
284
@escardio
European Society of Cardiology
2 years
Tweet media one
4
135
279
@escardio
European Society of Cardiology
1 year
#Colchicine does not significantly reduce perioperative #Afib or myocardial injury after non-cardiac surgery (MINS) in patients undergoing major non-cardiac thoracic surgery ⬇️ #ESCCongress COP-AF trial
Tweet media one
3
111
273
@escardio
European Society of Cardiology
4 years
Tweet media one
Tweet media two
Tweet media three
8
186
258
@escardio
European Society of Cardiology
6 years
A wonderful diagram on #hyperkalemia ECG signs. From Jason Winter, UK NHS Ambulance. #ESCardioED #cardioed #cardiotwitter
Tweet media one
2
152
251
@escardio
European Society of Cardiology
3 months
Aficamten for the treatment of symptomatic obstructive hypertrophic #cardiomyopathy - SEQUOIA-HCM study. #HeartFailure2024 #HFA_ESC
Tweet media one
2
124
258
@escardio
European Society of Cardiology
3 years
#LOOP Study: continuous heart rhythm monitoring – with anticoagulation if #AFib is detected – does not prevent #strokes in those at risk #ESCCongress
Tweet media one
1
112
254
@escardio
European Society of Cardiology
1 year
#ImageOfTheWeek by @KardiologieHH and Frank Hennersdorf from the Schön Clinic Hamburg Eilbek, Germany What is the likely cause of EKG- and echo-pathology? #cardioed #ESCYoung #cardiology #science #medicine #cardiovascular #health
Tweet media one
20
58
257
@escardio
European Society of Cardiology
3 years
#IAMI trial: #influenza vaccination reduces the risk of all-cause death, #MyocardialInfarction , or stent thrombosis at 12 months in hospitalised patients with myocardial infarction or high-risk #coronary disease #ESCCongress
Tweet media one
4
115
251
@escardio
European Society of Cardiology
1 year
#HFpEF is a challenging phenotype of #HeartFailure . Until recently, there were no approved or effective therapies to reduce mortality/morbidity. Clinical trials now show that the outcome of patients with HFpEF could be improved via the use of the news drugs, #SGLT2i and #ARNi
Tweet media one
1
121
253
@escardio
European Society of Cardiology
2 years
#EchoNet_RCT : In patients undergoing echocardiographic evaluation of #cardiac function, preliminary assessment by artificial intelligence is superior to initial sonographer assessment. #ESCCongress
Tweet media one
5
107
246
@escardio
European Society of Cardiology
6 years
What is the pathology of the mitral valve ? – by Miss Solange Fernandes, Barts Health Trust, London A) Double orifice B) Rheumatic C) Hypoplastic D) Parachute E) Arcade #HFA_ESC #ESCACCA #EACVI #cardiotwitter
91
112
243
@escardio
European Society of Cardiology
1 year
Extended #P2Y12 inhibitor monotherapy beyond 12 months after #PCI reduces bleeding and ischaemic events in #ACS patients at high risk for both types of events. #ESCCongress OPT-BIRISK trial - Extended clopidogrel monotherapy versus DAPT in high-risk patients.
Tweet media one
2
100
239
@escardio
European Society of Cardiology
5 years
JUST RELEASED: 2019 #ESCGuidelines for the management of Supraventricular Tachycardia - what's new? what has changed? what are the main 2019 recommendations? #ESCcongress #cardiotwitter
Tweet media one
Tweet media two
0
172
240
@escardio
European Society of Cardiology
4 years
Tweet media one
6
136
232
@escardio
European Society of Cardiology
3 years
#EMPEROR -Pooled trial: a pooled analysis of two randomised trials has demonstrated the beneficial effects of empagliflozin in patients with heart failure with a reduced and preserved ejection fraction #ESCCongress
Tweet media one
2
101
234
@escardio
European Society of Cardiology
4 years
Just released: 2020 ESC Guidelines on #SportCardiology and #Exercise in Patients with Cardiovascular Disease! #ESCCongress #ESCGuidelines #Cardiotwitter #MedTwitter #cardiovasculardisease
Tweet media one
0
129
225
@escardio
European Society of Cardiology
1 year
The diagnosis of #HeartFailure is more often missed than made, especially for women 👇 #HeartFailure2023 #HF #HFA_ESC
Tweet media one
0
96
225
@escardio
European Society of Cardiology
5 years
A 30-year-old woman, recurrent syncope; BP 90/60 - What's your initial management? A/ Adenosine 6 mg IV B/ Amiodarone 300 mg IV C/ Metoprolol 5 mg IV D/ Sedation + electrical synchronised cardioversion #ACUTECVDAYS #cardiotwitter #cardioed #ESCACCA #acutecare
Tweet media one
179
87
222
@escardio
European Society of Cardiology
1 year
Tweet media one
0
104
225
@escardio
European Society of Cardiology
4 years
2020 ESC Guidelines for the management of adult congenital heart disease just released #ESCCongress #ESCGuidelines #cardiotwitter
Tweet media one
0
106
219
@escardio
European Society of Cardiology
2 years
#DANFLU_1 trial: Innovative randomised trial shows high-dose influenza vaccination in older adults is associated with a reduced risk of death and lower incidence of hospitalisation for influenza or pneumonia compared with standard-dose vaccination. #ESCCongress
Tweet media one
2
87
212
@escardio
European Society of Cardiology
3 years
#STOPDAPT -2 ACS trial: 1-month #DAPT and subsequent clopidogrel monotherapy failed to achieve noninferiority for net clinical benefit compared with standard 12-month DAPT after #AcuteCoronarySyndrome #ESCCongress
Tweet media one
5
102
215
@escardio
European Society of Cardiology
6 years
#ESCardioEd Pathophysiology of functional tricuspid regurgitation. #EACVI #cardioed #ESCCoT
Tweet media one
0
119
210
@escardio
European Society of Cardiology
6 years
New #clinicalcase on our FB page #EHRA_ESC #cardiotwitter Happy monday everyone 😀
Tweet media one
9
25
191
@escardio
European Society of Cardiology
3 years
#FIGARO -DKD trial: finerenone reduces the risk of #cardiovascular morbidity and mortality in patients with mild-to-moderate kidney disease and type 2 #diabetes #ESCCongress
Tweet media one
0
100
211
@escardio
European Society of Cardiology
1 year
After a fantastic meeting we wish you safe travels home! Looking forward to next year in London😊 From tulips 🌷 to fish & chips 🐠😄 #ESCCongress
Tweet media one
7
32
212
@escardio
European Society of Cardiology
9 months
All you need to know about #CVD and #diabetes 👇 This month’s Focus has a special emphasis on the new #ESCGuidelines and how to overcome challenges in their implementation. These include #ESCCongresspresentations , webinars, journal articles, a textbook chapter and an ESC
Tweet media one
1
71
206
@escardio
European Society of Cardiology
4 years
Latest #ESCCardioMed update now available Did you know it has extensive #Interactive3D & animated videos? Get a feel for them #3DEducation #cardiotwitter #medtwitter #cardioed #ESCYoung @TomLuscher @johncamm
4
130
208
@escardio
European Society of Cardiology
3 years
#SSaSS : replacing salt with a low-sodium alternative lowers the risk of #stroke in people with high #BloodPressure or prior stroke #ESCCongress
Tweet media one
2
92
204
@escardio
European Society of Cardiology
7 years
The ESC offers condolences to #Barcelona attack victims. #ESCCongress scheduled in 8 days.It will proceed as planned
8
119
202
@escardio
European Society of Cardiology
4 years
#Coronavirus fulminant #myocarditis saved w/ glucocorticoid & human immunoglobulin #COVID19 #cardiotwitter #EHJ @ehj_ed
Tweet media one
3
141
203
@escardio
European Society of Cardiology
4 years
#DAPA -CKD trial: in patients with #CKD dapagliflozin reduced the risk of #kidney failure, reduced the risk of #cardiovascular death or #heartfailure hospitalisation, and prolonged survival #ESCCongress
Tweet media one
Tweet media two
1
125
201
@escardio
European Society of Cardiology
1 year
Intravascular imaging-guided percutaneous coronary intervention (PCI) is associated with a lower rate of target lesion failure compared with angiography-guided #PCI ⬇️ #ESCCongress OCT vs. IVUS vs. Angiography Guidance; a real-time updated network meta-analysis
Tweet media one
3
90
198
@escardio
European Society of Cardiology
6 years
A 48-year-old male patient is coming to your hospital in pulmonary edema. The patient is intubated & unable to provide any further history. What is the cause of the pulmonary edema? #cardiology #acute #challenge #ESCardioEd #cardiotwitter
36
101
192
@escardio
European Society of Cardiology
4 years
#POPULAR TAVI trial: aspirin alone after #TAVI reduces bleeding events and does not increase the rate of #thromboembolic events #ESCCongress
Tweet media one
Tweet media two
Tweet media three
Tweet media four
0
87
194
@escardio
European Society of Cardiology
1 year
A hearty round of applause to this year's winners at #ESCCongress . The path to finalising, submitting, and showcasing research demands dedication. Review the winning presentations Congratulations to everyone again😊 Well done!
Tweet media one
5
36
188
@escardio
European Society of Cardiology
4 years
Acute #myocarditis presenting as a reverse #Takotsubo syndrome in a patient with #COVID19 respiratory infection @ehj_ed #EHJ #cardiotwitter #COVID ー19
Tweet media one
8
115
190
@escardio
European Society of Cardiology
1 year
Friends, it's finally happening 🤗 Our #SoMe Ambassadors for #ESCGuidelines & Hot Lines 👉 @CMichaelGibson @VDelgadoGarcia @WilfriedMullens @mirvatalasnag @Drroxmehran @alaide_chief @DavidDuncker are ready to give you all the new science from #ESCCongress Follow their updates👍
9
55
191
@escardio
European Society of Cardiology
6 years
Severe aortic stenosis on a bicuspid valve – CMR by Dr. @Doc_Tiger Manchester Heart Center #whycmr #EACVI #cardiotwitter
3
84
190
@escardio
European Society of Cardiology
1 year
#ESCGuidelines for the management of #ACS ACS encompasses a spectrum🔽 Unstable #Angina / #NSTEMI / #STEMI #ESCCongress
@escardio
European Society of Cardiology
1 year
Tweet media one
4
406
954
0
97
188